Evidence map›Paper›PMID 28210565›Full record

ArticleFrontiers in oncology2017

Label-Free Proteome Analysis of Plasma from Patients with Breast Cancer: Stage-Specific Protein Expression.

Marina Duarte Pinto Lobo, Frederico Bruno Mendes Batista Moreno, Gustavo Henrique Martins Ferreira Souza, Sara Maria Moreira Lima Verde, Renato de Azevedo Moreira, Ana Cristina de Oliveira Monteiro-Moreira

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. High-Throughput Glycomic Methods.Chemical reviews · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Proteomics and its applications in breast cancer.American journal of cancer research · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Proteins Involved in the Induction of Procoagulant Activity and Autoimmune Response in Patients With Primary Antiphospholipid Syndrome.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marina Duarte Pinto LoboDepartment of Biochemistry and Molecular Biology, Federal University of Ceará (UFC), Fortaleza, Brazil; Center of Experimental Biology (Nubex), University of Fortaleza (UNIFOR), Fortaleza, Brazil.
Frederico Bruno Mendes Batista MorenoCenter of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
Gustavo Henrique Martins Ferreira SouzaMass Spectrometry Applications Research and Development Laboratory, Waters Corporation , São Paulo , Brazil.
Sara Maria Moreira Lima VerdeCenter of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
Renato de Azevedo MoreiraCenter of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
Ana Cristina de Oliveira Monteiro-MoreiraCenter of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
Universidade de Fortaleza · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the most commonly diagnosed types of cancer among women. Breast cancer mortality rates remain high probably because its diagnosis is hampered by inaccurate detection methods. Since changes in protein expression as well as modifications in protein glycosylation have been frequently reported in cancer development, the aim of this work was to study the differential expression as well as modifications of glycosylation of proteins from plasma of women with breast cancer at different stages of disease (

Indexed as

biomarkersbreast cancerlectinmass spectrometryMSE

Identifiers

PMID28210565
PMCPMC5288737
OpenAlexW2583212256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.